The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC

被引:5
作者
Turan, Gulay [1 ]
Altun, Eren [1 ]
Aslan, Figen [1 ]
Kulahci, Ozgur [2 ]
机构
[1] Balikesir Univ, Sch Med, Dept Pathol, Balikesir, Turkey
[2] Hlth Sci Univ, Adana Numune Training & Res Hosp, Dept Pathol, Adana, Turkey
关键词
Differential diagnosis; immunohistochemistry; keratoacanthoma; well-differentiated SCC; SQUAMOUS-CELL CARCINOMA; BIOLOGICAL BEHAVIOR; PROTEINS; RECEPTOR; BINDING; CYCLE; P21;
D O I
10.4103/IJPM.IJPM_752_18
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: We have aimed to evaluate the difference between the expression of p53, Ki-67, and laminin in keratoacanthoma and well-differentiated SCC (SCC) and to determine its importance in differential diagnosis. Methods: This study totally included 46 cases consisting of 23 cases with keratoacanthoma and 23 with SCC. As well as age, gender, localization, and diameter of the lesion, the expression of p53, Ki-67 and laminin was evaluated. Results: No statistically significant difference was found between KA and well-differentiated SCC in terms of diameter, age, and localization. There was a statistically significant difference between KA and well-differentiated SCC in terms of p53 and Ki-67 staining (P < 0.001). Increased expression of p53 and Ki-67 was found in well-differentiated SCC. A statistically significant correlation was present between the expression of p53 and Ki-67 in KA. A statistically significant difference was detected between KA and well-differentiated SCC in terms of laminin staining (P = 0.018). Increased laminin expression was determined in well-differentiated SCC. Conclusion: We have determined in this study that p53, Ki-67 and laminin may be used as adjuvant immunohistochemical markers in differential diagnosis of KA and well-differentiated SCC.
引用
收藏
页码:561 / 565
页数:5
相关论文
共 24 条
[1]   P53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases [J].
Batinac, T ;
Zamolo, G ;
Jonjic, N ;
Gruber, F ;
Petrovecki, M .
TUMORI, 2004, 90 (01) :120-127
[2]   Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma [J].
Batinac, Tanja ;
Zamolo, Gordana ;
Coklo, Miran ;
Hadzisejdic, Ita ;
Stemberger, Christophe ;
Zauhar, Gordana .
PATHOLOGY RESEARCH AND PRACTICE, 2006, 202 (08) :599-607
[3]   The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study [J].
Bedir, Recep ;
Gucer, Hasan ;
Sehitoglu, Ibrahim ;
Yurdakul, Cuneyt ;
Bagci, Pelin ;
Ustuner, Pelin .
BALKAN MEDICAL JOURNAL, 2016, 33 (02) :121-127
[4]   QUANTITATIVE IMAGE-ANALYSIS OF P53 PROTEIN ACCUMULATION IN KERATOACANTHOMAS [J].
BORKOWSKI, A ;
BENNETT, WP ;
JONES, RT ;
BORKOWSKI, P ;
HARRIS, CC ;
FERREIRA, LR ;
KAO, GF ;
TRUMP, BF .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1995, 17 (04) :335-338
[5]  
Brenn T, 2005, PATHOLOGY SKIN, V2, P1153
[6]   CD1A-positive cells and HSP60 (HSPD1) levels in keratoacanthoma and squamous cell carcinoma [J].
Cabibi, Daniela ;
de Macario, Everly Conway ;
Ingrao, Sabrina ;
Porcasi, Rossana ;
Zucco, Francesco ;
Macario, Alberto J. L. ;
Cappello, Francesco ;
Rappa, Francesca .
CELL STRESS & CHAPERONES, 2016, 21 (01) :131-137
[7]   KERATOACANTHOMA VERSUS SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL REAPPRAISAL OF P53 PROTEIN AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN KERATOACANTHOMA-LIKE TUMORS [J].
CAIN, CT ;
NIEMANN, TH ;
ARGENYI, ZB .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1995, 17 (04) :324-331
[8]  
CASTRONOVO V, 1993, INVAS METAST, V13, P1
[9]   Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma [J].
Connolly, M. ;
Narayan, S. ;
Oxley, J. ;
de Berker, D. A. R. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (05) :625-628
[10]  
Cotran RS, 1994, PATHOLOGIC BASIS DIS, P272